ZMAT1

gene
On this page

Also known as KIAA1789

Summary

ZMAT1 (zinc finger matrin-type 1, HGNC:29377) is a protein-coding gene on chromosome Xq22.1, encoding Zinc finger matrin-type protein 1 (Q5H9K5).

This gene encodes a protein containing Cys2-His2 (C2H2)-type zinc fingers, which are similar to those found in the nuclear matrix protein matrin 3. Alternatively spliced transcript variants have been found for this gene.

Source: NCBI Gene 84460 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 112 total
  • MANE Select transcript: NM_001394560

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29377
Approved symbolZMAT1
Namezinc finger matrin-type 1
LocationXq22.1
Locus typegene with protein product
StatusApproved
AliasesKIAA1789
Ensembl geneENSG00000166432
Ensembl biotypeprotein_coding
OMIM301007
Entrez84460

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 6 protein_coding, 4 protein_coding_CDS_not_defined

ENST00000372782, ENST00000458570, ENST00000488347, ENST00000490757, ENST00000494068, ENST00000540921, ENST00000651725, ENST00000878189, ENST00000878190, ENST00000966029

RefSeq mRNA: 4 — MANE Select: NM_001394560 NM_001011657, NM_001282400, NM_001282401, NM_001394560

CCDS: CCDS35348, CCDS94643

Canonical transcript exons

ENST00000651725 — 6 exons

ExonStartEnd
ENSE00001458637101882290101884821
ENSE00003503232101897868101898042
ENSE00003510523101904224101904330
ENSE00003554317101886632101886731
ENSE00003635776101898119101898220
ENSE00003845432101931717101932027

Expression profiles

Bgee: expression breadth ubiquitous, 234 present calls, max score 96.10.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.2139 / max 339.1804, expressed in 1139 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1999647.60411116
1999650.6098312

Top tissues by expression

251 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right uterine tubeUBERON:000130296.10gold quality
adenohypophysisUBERON:000219695.67gold quality
pituitary glandUBERON:000000795.29gold quality
sural nerveUBERON:001548895.25gold quality
left lobe of thyroid glandUBERON:000112094.23gold quality
thyroid glandUBERON:000204693.97gold quality
oviduct epitheliumUBERON:000480493.94gold quality
right lobe of thyroid glandUBERON:000111993.79gold quality
tibial nerveUBERON:000132393.77gold quality
ventricular zoneUBERON:000305391.74gold quality
epithelial cell of pancreasCL:000008391.25gold quality
corpus epididymisUBERON:000435991.14gold quality
left ovaryUBERON:000211990.82gold quality
calcaneal tendonUBERON:000370190.61gold quality
corpus callosumUBERON:000233689.43gold quality
right ovaryUBERON:000211889.08gold quality
right coronary arteryUBERON:000162589.02gold quality
C1 segment of cervical spinal cordUBERON:000646988.92gold quality
thymusUBERON:000237088.90gold quality
ovaryUBERON:000099288.71gold quality
metanephros cortexUBERON:001053388.70gold quality
body of pancreasUBERON:000115088.66gold quality
spinal cordUBERON:000224088.61gold quality
cardiac muscle of right atriumUBERON:000337987.94silver quality
nucleus accumbensUBERON:000188287.68gold quality
amygdalaUBERON:000187687.65gold quality
popliteal arteryUBERON:000225087.52gold quality
tibial arteryUBERON:000761087.52gold quality
caudate nucleusUBERON:000187387.46gold quality
mucosa of stomachUBERON:000119987.24gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.70
E-CURD-135no912.66
E-MTAB-4850no2.03

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

94 targeting ZMAT1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-5692A100.0074.406850
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-453199.9969.703181
HSA-MIR-485-3P99.9870.681585
HSA-MIR-539-3P99.9870.741616
HSA-MIR-302C-5P99.9772.563642
HSA-MIR-6888-3P99.9765.951170
HSA-MIR-365899.9673.874379
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-568899.9673.234504
HSA-MIR-495-3P99.9672.814197
HSA-MIR-391099.9571.132227
HSA-MIR-4778-3P99.9370.401818
HSA-MIR-335-3P99.9373.364958
HSA-MIR-311999.9271.342390
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-6809-3P99.9171.453814

Literature-anchored findings (GeneRIF, showing 2)

  • Suggest that ZMAT1 transcript variant 2 is a potential diagnostic factor in patients with gastric cancer. (PMID:26191264)
  • ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway. (PMID:35392973)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriozmat1ENSDARG00000058679
mus_musculusZmat1ENSMUSG00000052676
rattus_norvegicusZmat1ENSRNOG00000024135
drosophila_melanogasterCG1231FBGN0035134
drosophila_melanogasterdbfFBGN0287630

Paralogs (9): ZNF346 (ENSG00000113761), ZNF385B (ENSG00000144331), ZMAT2 (ENSG00000146007), ZNF385D (ENSG00000151789), ZNF385A (ENSG00000161642), ZMAT4 (ENSG00000165061), KRCC1 (ENSG00000172086), ZMAT3 (ENSG00000172667), ZNF385C (ENSG00000187595)

Protein

Protein identifiers

Zinc finger matrin-type protein 1Q5H9K5 (reviewed: Q5H9K5)

All UniProt accessions (1): Q5H9K5

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Nucleus.

Isoforms (3)

UniProt IDNamesCanonical?
Q5H9K5-11yes
Q5H9K5-22
Q5H9K5-33

RefSeq proteins (4): NP_001011657, NP_001269329, NP_001269330, NP_001381489* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR003604Matrin/U1-like-C_Znf_C2H2Domain
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF12874

UniProt features (13 total): compositionally biased region 5, zinc finger region 3, splice variant 2, chain 1, sequence variant 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5H9K5-F151.410.03

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 83 (showing top): GCAAGGA_MIR502, LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN, MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN, JAATINEN_HEMATOPOIETIC_STEM_CELL_UP, WANG_TUMOR_INVASIVENESS_UP, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN, chrXq22, TTTGCAG_MIR518A2, LINDGREN_BLADDER_CANCER_CLUSTER_1_UP, GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN, PEDRIOLI_MIR31_TARGETS_DN, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GSE14415_ACT_VS_CTRL_NATURAL_TREG_UP, GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP, HES2_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (4): DNA binding (GO:0003677), zinc ion binding (GO:0008270), nucleic acid binding (GO:0003676), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
nucleic acid binding1
transition metal ion binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

774 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZMAT1C3orf22Q8N5N4432
ZMAT1DUXBA0A1W2PPF3423
ZMAT1RNASE12Q5GAN4413
ZMAT1TPRX1Q8N7U7408
ZMAT1LCN6P62502394
ZMAT1LEUTXA8MZ59387
ZMAT1DUXAA6NLW8383
ZMAT1SMIM17P0DL12380
ZMAT1DRGXA6NNA5379
ZMAT1C12orf56Q8IXR9378
ZMAT1NEMP2A6NFY4373
ZMAT1PABIR3Q6P4D5371
ZMAT1ZNF836Q6ZNA1367
ZMAT1UNCXA6NJT0366
ZMAT1ALX3O95076366

IntAct

11 interactions, top by confidence:

ABTypeScore
ZMAT1GORASP2psi-mi:“MI:0915”(physical association)0.550
ZMAT1taxpsi-mi:“MI:0915”(physical association)0.490
ZMAT1H2AXpsi-mi:“MI:0915”(physical association)0.400
ZMAT1GRB2psi-mi:“MI:0915”(physical association)0.370
PIK3R3ZMAT1psi-mi:“MI:0915”(physical association)0.370
FMR1ZMAT1psi-mi:“MI:0915”(physical association)0.000
cls2ZMAT1psi-mi:“MI:0915”(physical association)0.000
ZMAT1fadLpsi-mi:“MI:0915”(physical association)0.000

BioGRID (33): ZMAT1 (Two-hybrid), ZMAT1 (Two-hybrid), ZMAT1 (Two-hybrid), ZMAT1 (Two-hybrid), ZMAT1 (Synthetic Lethality), ZMAT1 (Two-hybrid), ZMAT1 (Two-hybrid), ZMAT1 (Two-hybrid), ZMAT1 (Affinity Capture-RNA), ZMAT1 (Two-hybrid), ZMAT1 (Two-hybrid), ZMAT1 (Two-hybrid), ZMAT1 (Two-hybrid), ZMAT1 (Two-hybrid), ZMAT1 (Two-hybrid)

ESM2 similar proteins: A0JM80, A6H8Y1, A7MBJ2, D3ZF42, E9Q6J5, F4I700, F4J3S1, F4KCE9, F6QRE9, O04251, O82345, P23497, P46100, P48785, P48786, Q04996, Q05B65, Q0WTB8, Q13342, Q15361, Q32MZ4, Q3UZ39, Q3ZBR9, Q4QSC8, Q571C7, Q5H9K5, Q5RHP9, Q61687, Q66HF9, Q7YQM3, Q7YQM4, Q7Z5L2, Q8BJM3, Q8C4A5, Q8C9B9, Q8GZ87, Q8H991, Q8IW19, Q92576, Q940Y3

Diamond homologs: A0A096LPI5, A6NIU2, A6NJG6, F2Z398, P0DTE4, P51957, Q09FC8, Q5H9K5, Q5T7P6, Q68CZ1, Q6B4Z3, Q6UX73, Q86U02, Q8IV13, Q8N7M2, Q8N9N2, Q8NDZ0, Q8NEM8, Q8TDM0, Q92918, Q96J02, Q96MD7, Q9BUA6, Q9NXG0, A2RV29, B0JZ85, O08781, O54836, Q0IIC4, Q0VD35, Q28EG9, Q5R4W8, Q8AVN9, Q8BZ94, Q9H898, Q9HA38, Q9R0B7, Q9UL40, Q8N2A0, Q96M98

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

112 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance49
Likely benign6
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

926 predictions. Top by Δscore:

VariantEffectΔscore
X:101884817:ATTCT:Aacceptor_gain1.0000
X:101884818:TTCT:Tacceptor_gain1.0000
X:101884820:CT:Cacceptor_gain1.0000
X:101884821:TC:Tacceptor_loss1.0000
X:101884822:C:CCacceptor_gain1.0000
X:101884824:G:Cacceptor_gain1.0000
X:101897862:CCTTA:Cdonor_loss1.0000
X:101897863:CTTAC:Cdonor_loss1.0000
X:101897864:TTA:Tdonor_loss1.0000
X:101897866:AC:Adonor_gain1.0000
X:101897867:CC:Cdonor_gain1.0000
X:101897867:CCCAT:Cdonor_gain1.0000
X:101904219:CCTA:Cdonor_loss1.0000
X:101904220:CTAC:Cdonor_loss1.0000
X:101904221:TACC:Tdonor_loss1.0000
X:101904222:ACCTC:Adonor_loss1.0000
X:101904223:C:CTdonor_loss1.0000
X:101904288:T:Cdonor_gain1.0000
X:101904328:CGT:Cacceptor_gain1.0000
X:101904329:GTCT:Gacceptor_loss1.0000
X:101904330:TCTG:Tacceptor_loss1.0000
X:101904331:C:CCacceptor_gain1.0000
X:101904331:CT:Cacceptor_loss1.0000
X:101904332:T:Cacceptor_loss1.0000
X:101904337:A:ACacceptor_gain1.0000
X:101884819:TCT:Tacceptor_gain0.9900
X:101884820:CTC:Cacceptor_gain0.9900
X:101884821:TCT:Tacceptor_gain0.9900
X:101884822:C:Aacceptor_gain0.9900
X:101884824:G:GCacceptor_gain0.9900

AlphaMissense

4633 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
X:101883534:C:AW631C0.996
X:101883534:C:GW631C0.996
X:101883536:A:GW631R0.994
X:101883536:A:TW631R0.994
X:101886658:G:CH193Q0.990
X:101886658:G:TH193Q0.990
X:101886660:G:CH193D0.989
X:101883527:A:GS634P0.988
X:101886640:A:CH199Q0.988
X:101886640:A:TH199Q0.988
X:101886668:A:GF190S0.987
X:101886708:A:GC177R0.987
X:101883535:C:GW631S0.985
X:101883513:A:CF638L0.984
X:101883513:A:TF638L0.984
X:101883515:A:GF638L0.984
X:101886685:A:CF184L0.983
X:101886685:A:TF184L0.983
X:101886686:A:GF184S0.983
X:101886687:A:GF184L0.983
X:101886697:A:CC180W0.983
X:101886699:A:GC180R0.982
X:101886706:G:CC177W0.982
X:101886642:G:CH199D0.981
X:101897983:A:CF130L0.981
X:101897983:A:TF130L0.981
X:101897985:A:GF130L0.981
X:101883538:A:GL630P0.980
X:101897956:G:CH139Q0.980
X:101897956:G:TH139Q0.980

dbSNP variants (sampled 300 via entrez): RS1000195964 (X:101909663 G>A,T), RS1000211268 (X:101918587 G>A), RS1000233292 (X:101924407 C>G,T), RS1000351001 (X:101902556 T>G), RS1000363227 (X:101913886 T>A,C), RS1000373813 (X:101927716 T>C,G), RS1000413696 (X:101907864 C>T), RS1000514343 (X:101922559 A>C,G), RS1000523236 (X:101933685 T>G), RS1000576157 (X:101911607 C>T), RS1000583142 (X:101922109 G>T), RS1000661855 (X:101925308 G>C), RS1000776974 (X:101933746 T>C), RS1000985360 (X:101889382 T>G), RS1001165761 (X:101892003 C>A)

Disease associations

OMIM: gene MIM:301007 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

23 total (human), top 23 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Aciddecreases expression, decreases methylation, affects cotreatment6
perfluorooctane sulfonic aciddecreases expression2
aristolochic acid Idecreases expression1
GSK-J4decreases expression1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
trichostatin Aincreases expression1
perfluorooctanoic aciddecreases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
perfluoro-n-nonanoic aciddecreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamidedecreases expression, affects cotreatment1
perfluorohexanesulfonic aciddecreases expression1
dorsomorphinaffects cotreatment, decreases expression1
Sunitinibincreases expression1
Acetaminophenincreases expression1
Benzo(a)pyreneaffects methylation1
Oxygenincreases expression1
Silicon Dioxidedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Cyclosporineincreases expression1
Aflatoxin B1decreases methylation1
Okadaic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.